This report contains market size and forecasts of Drug-Eluting Stent in global, including the following market information:
Global Drug-Eluting Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drug-Eluting Stent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drug-Eluting Stent companies in 2021 (%)
The global Drug-Eluting Stent market was valued at 6126.3 million in 2021 and is projected to reach US$ 7715.4 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapamycin Eluting Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug-Eluting Stent include Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo and Biosensors International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug-Eluting Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug-Eluting Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Stent Market Segment Percentages, by Type, 2021 (%)
Rapamycin Eluting Stent
Paclitaxel Eluting Stent
Everolimus Eluting Stent
Others
Global Drug-Eluting Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Stent Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Drug-Eluting Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Stent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug-Eluting Stent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drug-Eluting Stent revenues share in global market, 2021 (%)
Key companies Drug-Eluting Stent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drug-Eluting Stent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO